Oriola-KD's new guidelines for net sales and operating profit in 2011

Oriola-KD Corporation Stock Exchange Release 16 December 2011 at 8.30 a.m.

Guidelines issued on 19 July 2011

Oriola-KD's net sales are expected to increase over 10 per cent in 2011 compared
to the previous year. Operating profit excluding one-off items and impairment
charges is expected to exceed EUR 20 million in 2011.

New guidelines issued on 16 December 2011

Oriola-KD's net sales are expected to increase approximately 11 per cent in
2011 compared to the previous year. Operating profit excluding one-off items and
impairment charges is expected to be EUR 12-15 million in 2011.

The operating loss of the pharmaceutical businesses in Russia, and especially of
pharmaceutical wholesale, for the full year 2011 decreases significantly Oriola-
KD's operating profit in 2011.

Oriola-KD Corporation

Eero Hautaniemi
President and CEO

Kimmo Virtanen
Executive Vice President and CFO

Further information:

Kimmo Virtanen
Executive Vice President and CFO
tel. +358 (0)10 429 2069
e-mail: kimmo.virtanen@oriola-kd.com

Pellervo Hämäläinen
Vice President, Communications and Investor Relations
tel. +358 (0)10 429 2497
e-mail: pellervo.hamalainen@oriola-kd.com

Distribution
NASDAQ OMX Helsinki Ltd
Principal media

Published by:
Oriola-KD Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoo, Finland
www.oriola-kd.com



[HUG#1571888]